Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/17/2014WO2014057118A1 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
04/17/2014WO2014057115A1 Pyrrolobenzodiazepine-anti-her2 antibody conjugates
04/17/2014WO2014057103A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/17/2014WO2014057080A2 Cyclic amines
04/17/2014WO2014057069A1 Liquid pharmaceutical composition of factor vii polypeptide
04/17/2014WO2014057068A1 Liquid pharmaceutical composition of factor vii polypeptide
04/17/2014WO2014057067A1 Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms
04/17/2014WO2014057003A1 Novel uses
04/17/2014WO2014056958A1 Substituted phenylcarbamate compounds
04/17/2014WO2014056955A1 Process for making thienopyrimidine compounds
04/17/2014WO2014056953A1 Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
04/17/2014WO2014056938A1 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
04/17/2014WO2014056928A1 Methods for predicting multiple myeloma treatment response
04/17/2014WO2014056897A1 Combination of opioids and anticancer drugs for cancer treatment
04/17/2014WO2014056894A1 Mek inhibitors in the treatment of virus diseases
04/17/2014WO2014056882A1 Dosage forms containing terbutaline sulphate
04/17/2014WO2014056871A1 Azaindolines
04/17/2014WO2014056867A1 Azaindolines
04/17/2014WO2014056852A1 Labeled ligands of the oxytocin receptor
04/17/2014WO2014056841A1 Modified hyaluronic acid derivatives and use thereof
04/17/2014WO2014056840A1 Beta-2-adrenoceptor agonist for the treatment of cough
04/17/2014WO2014056779A1 Drug for the prophylaxis and treatment of a neurodegenerative disease
04/17/2014WO2014056771A1 New pyrrolidine derivatives and their use as acetyl-coa carboxylase inhibitors
04/17/2014WO2014056755A1 Indolines
04/17/2014WO2014056723A1 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and on hydroxyapatite, for therapeutic use
04/17/2014WO2014056710A1 Arylethynyl derivatives
04/17/2014WO2014056627A1 Novel approaches for individualized therapy of pancreatic ductal adenocarcinoma
04/17/2014WO2014056623A2 Tyrosinase inhibitors for depigmentation or hair removal
04/17/2014WO2014056620A1 Treatment and/or prophylaxis of tspo mediated diseases and/or disorders
04/17/2014WO2014056566A1 Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a mek inhibitor
04/17/2014WO2014056446A1 Phenyl 1,2-isoxazolyl or phenyl 1,2-pyrazole compound and application thereof
04/17/2014WO2014056434A1 Crystalline form and amorphous form of apixaban and preparation thereof
04/17/2014WO2014056418A1 Pharmaceutical composition containing aspirin and vicagrel
04/17/2014WO2014056401A1 Double-bond substituted tripterygium wilfordii lactone derivative and preparation method and use thereof
04/17/2014WO2014056396A1 Flumatinib mesylate crystal form and preparation method and use thereof
04/17/2014WO2014056280A1 Microencapsulated amino acid composition and preparation method thereof
04/17/2014WO2014056270A1 Targeting thymidine kinase photosensitizer and pharmaceutical composition and use for cancer treatment thereof
04/17/2014WO2014056083A1 Kinase inhibitors and method of treating cancer with same
04/17/2014WO2014056070A1 (-)-deprenyl and related compounds for the treatment of alopecia
04/17/2014WO2014056038A1 Novel flavonoid compounds and uses thereof
04/17/2014WO2014036556A3 Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine
04/17/2014WO2014036528A3 Agents useful for treating obesity, diabetes and related disorders
04/17/2014WO2014033551A3 The use of direct thrombin inhibitors in critically ill patients
04/17/2014WO2014031438A3 SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
04/17/2014WO2014030142A3 Nitroimidazole compounds and their use in cancer therapy
04/17/2014WO2014030096A3 Genes and processes for the production of clavine-type alkaloids
04/17/2014WO2014029888A3 Branched or macrocyclic polyamines and uses thereof
04/17/2014WO2014028591A3 N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
04/17/2014WO2014025958A3 Treatment of immune-related and inflammatory diseases
04/17/2014WO2014011695A3 Prodrugs of peptide epoxy ketone protease inhibitors
04/17/2014WO2014009738A3 Treatment of muscular dystrophy
04/17/2014WO2014008477A3 Activation by physical stimuli and role for trpv4 in organ-specific inflammation and itch
04/17/2014WO2013171332A3 Tertiary amines for use in the treatment of cardiac disorders
04/17/2014WO2013109216A3 Preparation of dry powder formulations comprising tiotropium
04/17/2014WO2013067483A8 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts
04/17/2014WO2013064461A3 Compounds with nematicidal activity
04/17/2014WO2013061004A8 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
04/17/2014WO2013059610A9 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
04/17/2014WO2013006619A9 Rna-yy1 interactions
04/17/2014WO2012148494A3 Pharmaceutical compositions containing paclitaxel orotate
04/17/2014WO2012121977A3 Dodecafluoropentane emulsion as a stroke and ischemia therapy
04/17/2014WO2012119006A3 Derivatives of pyrazole-substituted amino-heteroaryl compounds
04/17/2014WO2012116050A3 Phosphorus containing compounds as protein kinase inhibitors
04/17/2014WO2012112340A3 Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals
04/17/2014WO2012109469A3 Methods of treating alzheimer's disease with apo a-1 milano
04/17/2014WO2012103393A3 Controlling mealybugs
04/17/2014WO2012103071A3 Compounds and compositions
04/17/2014WO2012074980A3 Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives
04/17/2014US20140109245 Prostate cancer cell lines, gene signatures and uses thereof
04/17/2014US20140107594 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
04/17/2014US20140107568 Method of determining an injected dose based on a known oral dose
04/17/2014US20140107560 Compositions for solubilizing cells and/or tissue
04/17/2014US20140107391 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
04/17/2014US20140107345 Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
04/17/2014US20140107332 Series of drugs using photofrin to catalyze decomposition of hydrogen peroxide
04/17/2014US20140107227 Mucoadhesive drug delivery devices and methods of making and using thereof
04/17/2014US20140107225 Therapeutic application of cembranoids against hiv virus replication, hiv-associated neurocognitive disorders and hiv virus-induced inflammation.
04/17/2014US20140107224 Generation of therapeutic microfoam
04/17/2014US20140107223 Topical ubiquinol supplement skin care compositions
04/17/2014US20140107222 Treatments for social learning disorders
04/17/2014US20140107219 Local anaesthetic
04/17/2014US20140107218 Methods for maintaining eye health and ameliorating opthalmic maladies in animals
04/17/2014US20140107215 Clenbuterol for use in treatment of autism
04/17/2014US20140107213 Methods for administration of colchicine with grapefruit juice
04/17/2014US20140107212 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
04/17/2014US20140107211 Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
04/17/2014US20140107210 Method of treating post-surgical acute pain
04/17/2014US20140107209 Formulations of low dose diclofenac and beta-cyclodextrin
04/17/2014US20140107207 Method for Inactivating Viruses With Slightly Acidic Arginine
04/17/2014US20140107206 Omega-3 pentaenoic acid compositions and methods of use
04/17/2014US20140107205 Omega-3 pentaenoic acid compositions and methods of use
04/17/2014US20140107204 Method of administering ethanolamine 9-octadecanoic acid via injection to the stomach of a human
04/17/2014US20140107203 Pharmaceutical semi-solid composition of isotretinoin
04/17/2014US20140107201 Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function
04/17/2014US20140107200 Omega-3 pentaenoic acid compositions and methods of use
04/17/2014US20140107199 Omega-3 pentaenoic acid compositions and methods of use
04/17/2014US20140107198 Omega-3 pentaenoic acid compositions and methods of use
04/17/2014US20140107197 Pharmaceutical composition
04/17/2014US20140107196 Anti-cancer lead molecule
04/17/2014US20140107195 Water-swellable polymers
1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 7860